Abstract

In the last decade, extended-spectrum cephalosporin and carbapenem resistant Gram-negative bacilli (GNB) have been extensively reported in the literature as being disseminated in humans but also in animals and the environment. These resistant organisms often cause treatment challenges due to their wide spectrum of antibiotic resistance. With the emergence of colistin resistance in animals and its subsequent detection in humans, the situation has worsened. Several studies reported the transmission of resistant organisms from animals to humans. Studies from the middle east highlight the spread of resistant organisms in hospitals and to a lesser extent in livestock and the environment. In view of the recent socio-economical conflicts that these countries are facing in addition to the constant population mobilization; we attempt in this review to highlight the gaps of the prevalence of resistance, antibiotic consumption reports, infection control measures and other risk factors contributing in particular to the spread of resistance in these countries. In hospitals, carbapenemases producers appear to be dominant. In contrast, extended spectrum beta lactamases (ESBL) and colistin resistance are becoming a serious problem in animals. This is mainly due to the continuous use of colistin in veterinary medicine even though it is now abandoned in the human sphere. In the environment, despite the small number of reports, ESBL and carbapenemases producers were both detected. This highlights the importance of the latter as a bridge between humans and animals in the transmission chain. In this review, we note that in the majority of the Middle Eastern area, little is known about the level of antibiotic consumption especially in the community and animal farms. Furthermore, some countries are currently facing issues with immigrants, poverty and poor living conditions which has been imposed by the civil war crisis. This all greatly facilitates the dissemination of resistance in all environments. In the one health concept, this work re-emphasizes the need to have global intervention measures to avoid dissemination of antibiotic resistance in humans, animals and the environment in Middle Eastern countries.

Highlights

  • In the 1940s, the discovery of antibiotics was seen as one of medicine’s major achievements that saved millions of lives (van Hoek et al, 2011)

  • This review shows the extensive dissemination of extended spectrum beta lactamases (ESBL) and carbapenemase producing Gram-negative bacilli (GNB) in Middle Eastern hospitals

  • The prevalence of these multi-drug resistant organisms (MDROs) is less well documented in animals and the environment

Read more

Summary

INTRODUCTION

In the 1940s, the discovery of antibiotics was seen as one of medicine’s major achievements that saved millions of lives (van Hoek et al, 2011). It is worth mentioning that ESBL producers coresistant to non-beta lactam antibiotics is of special interest in this category; this is in view of the narrow choice of antibiotics that could be used in this category of patients (AlMayahie, 2013) In this country, CTX-M, SHV, TEM, and OXA ESBLs were described in clinical isolates of Morganella morganii with high resistance toward minocycline, trimethoprim- sulfamethoxazole and ciprofloxacin (Al-Muhanna et al, 2016). Another study reported different sequence types of K. pneumoniae detected in hospitalized patients: ST677, ST16, ST107, and ST485 producing CTX-M-15, SHV-11, and CTX-M14 beta lactamases (Jamal et al, 2015). One study addressing the hajj pilgrims of Marseille, reported the detection of 2 CTX-M-2 producing Salmonella spp Both strains were gentamicin and colistin resistant, in addition, they belonged to the epidemic Newport serotype ST45 (Olaitan et al, 2015). As for AmpC production, CMY variants (CMY-2, CMY-42, CMY-102), DHA-1, EBC, FOX, and MOX were detected

Animals Community environment Humans Community environment Humans Humans Humans
Hospital environment Humans Humans
Animals Humans
Plasmid type
Animals Animals
Infections With Carbapenemase Producers
NDM VIM
Humans Hospital environment Humans
Humans Humans Humans Humans
VIM Class D Oxacillinase NDM
Clinical samples Animal
Carbapenem and Colistin Resistance
Community Environment
Hospital Environment
Clinical Setting and Community
Animals and Environment
Findings
CONCLUSION
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.